Rebecca E McIntyre
Principal Staff Scientist
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (3)
Most genetic variants associated with complex diseases lie in non-coding regions, complicating efforts to identify effector genes and relevant cell types. Here, we map cis-eQTLs across 2.2 million single cells from blood and intestinal biopsies of 421 individuals, including 125 with inflammatory bowel disease (IBD). Cell-type-level eQTLs were more distal to transcription start sites, enriched in enhancers, less likely to regulate the nearest gene, and over two-fold more likely to colocalise with IBD GWAS loci than eQTLs detected at tissue-level resolution. We nominate effector genes at over half of known IBD loci, including MAML2 , PSEN2, and ZMIZ1 in myeloid cells, implicating reduced Notch signalling in intestinal immune dysfunction. We also identify Wnt regulated genes, including MYC , in epithelial stem and progenitor cells, suggesting that impaired renewal contributes to barrier breakdown. Our results provide a mechanistic map linking genetic risk to specific genes and cell types in IBD, and a framework for effector gene discovery in complex disease.
Year:
2025
Genomic instability arising from defective responses to DNA damage 1 or mitotic chromosomal imbalances 2 can lead to the sequestration of DNA in aberrant extranuclear structures called micronuclei (MN). Although MN are a hallmark of ageing and diseases associated with genomic instability, the catalogue of genetic players that regulate the generation of MN remains to be determined. Here we analyse 997 mouse mutant lines, revealing 145 genes whose loss significantly increases ( n = 71) or decreases ( n = 74) MN formation, including many genes whose orthologues are linked to human disease. We found that mice null for Dscc1 , which showed the most significant increase in MN, also displayed a range of phenotypes characteristic of patients with cohesinopathy disorders. After validating the DSCC1 -associated MN instability phenotype in human cells, we used genome-wide CRISPR–Cas9 screening to define synthetic lethal and synthetic rescue interactors. We found that the loss of SIRT1 can rescue phenotypes associated with DSCC1 loss in a manner paralleling restoration of protein acetylation of SMC3. Our study reveals factors involved in maintaining genomic stability and shows how this information can be used to identify mechanisms that are relevant to human disease biology 1 .
Year:
2024
Year:
2023
Collaborators (17)
Natalie Prescott
King’s College London
Carl Anderson
Head of Human Genetics
Wellcome Sanger Institute
Tim Raine
Cambridge University Hospitals NHS Foundation Trust
Gareth-Rhys Jones
Clinical Lecturer
-
Miles Parkes
Professor
Cambridge University Hospitals
Cristina Cotobal
Senior Staff Scientist
Wellcome Sanger Institute
Tobi Alegbe
Single-cell data scientist
European Bioinformatics Institute
Gabriel Balmus
Principal Investigator
University of Cambridge
James L Alexander
Academic Clinical Lecturer
Imperial College Healthcare NHS Trust
Panteleimon Takis
Assistant Professor
University of Ioannina
Elena Chekmeneva
Research Associate Structure Elucidation
Imperial College London
Chris Wallace
Director of Research
University of Cambridge
David Adams
Senior Group Leader (and Interim Programme Head)
Wellcome Sanger Institute
Peter Irving
King’s College London
Stefan Geyer
Associate Professor
Medical University of Vienna
Ruth Verstraten
Wellcome Sanger Institute
Christopher A. Lamb
Professor of Gastroenterology
Newcastle University
Make your next move.
Prepare your application
Review drafts before you send them.